Insider: Betz Stephen F. Chief Scientific Officer - Crinetics Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 99,713 | 0 | 99,713 |
| Value | $4,491,572.09 | $0.00 | $4,491,572.09 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 06/12/2025 | DDS | 97,483 | Direct | COM | $32.23 | $3,141,877.09 | 99,713 |
| 03/19/2025 | DDS | 5,479 | Direct | COM | $34.17 | $187,217.43 | 108,879 |
| 03/19/2025 | DDS | 291 | Direct | COM | $34.83 | $10,135.53 | 108,588 |
| 09/10/2024 | DDS | 1,035 | Direct | COM | $51.50 | $53,302.50 | 68,576 |
| 08/26/2024 | DDS | 3,000 | Direct | COM | $53.19 | $159,570.00 | 69,611 |
| 08/12/2024 | DDS | 3,000 | Direct | COM | $47.68 | $143,040.00 | 72,611 |
| 07/10/2024 | DDS | 3,000 | Direct | COM | $48.55 | $145,650.00 | 78,611 |
| 06/25/2024 | DDS | 3,000 | Direct | COM | $45.37 | $136,110.00 | 80,643 |
| 06/10/2024 | DDS | 3,000 | Direct | COM | $43.86 | $131,580.00 | 83,643 |
| 05/28/2024 | DDS | 3,000 | Direct | COM | $47.49 | $142,470.00 | 86,643 |
| 05/10/2024 | DDS | 3,000 | Direct | COM | $49.43 | $148,290.00 | 89,643 |
| 01/25/2024 | DDS | 3,000 | Direct | COM | $37.26 | $111,780.00 | 73,298 |
| 01/10/2024 | DDS | 3,000 | Direct | COM | $37.65 | $112,950.00 | 76,298 |
| 12/26/2023 | DDS | 3,000 | Direct | COM | $35.89 | $107,670.00 | 79,298 |
| 12/11/2023 | DDS | 3,000 | Direct | COM | $32.87 | $98,610.00 | 82,298 |
| 11/27/2023 | DDS | 3,000 | Direct | COM | $31.84 | $95,520.00 | 85,298 |
| 02/01/2023 | DDS | 3,126 | Direct | COM | $19.59 | $61,238.34 | 64,689 |
| 01/25/2023 | DDS | 8,336 | Direct | COM | $21.07 | $175,639.52 | 67,815 |
| 01/17/2023 | DDS | 3,126 | Direct | COM | $18.00 | $56,268.00 | 76,151 |
| 01/03/2023 | DDS | 3,126 | Direct | COM | $18.35 | $57,362.10 | 79,277 |
| 12/15/2022 | DDS | 3,126 | Direct | COM | $16.00 | $50,016.00 | 82,403 |
| 12/01/2022 | DDS | 3,126 | Direct | COM | $17.84 | $55,767.84 | 84,968 |
| 11/15/2022 | DDS | 3,126 | Direct | COM | $18.72 | $58,518.72 | 88,094 |
| 11/01/2022 | DDS | 3,126 | Direct | COM | $18.52 | $57,893.52 | 91,220 |
| 10/17/2022 | DDS | 3,126 | Direct | COM | $17.73 | $55,423.98 | 94,346 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research